SENS SenseonicsAnalyst actions

Raymond James Upgrades Senseonics to Market Perform from Underperform

Raymond James published no price target with the change, moving from underperform to market perform.

Close up of diabetic doing blood glucose  level test
Photo: Ground Picture/Shutterstock.com

Key points

  • Raymond James upgraded Senseonics to market perform from underperform before the open
  • No price target was published with the change
  • Five firms covered the stock in the past year; median target $14.00
  • Stock closed at $9.80 on Nov. 9, 2026, up 6.1% over 20 sessions

Raymond James upgraded Senseonics Holdings, Inc. (Nasdaq: SENS) to market perform from underperform before the open on Tuesday, Nov. 10, 2026. The firm did not publish a price target with the change.

The move takes Raymond James from a negative stance to a neutral one. Across the five firms that covered the stock in the past year, the median price target was $14.00, ranging from $8.00 to $18.00.

The stock closed at $9.80 on Monday, Nov. 9, 2026, and had risen 6.1% over the 20 sessions to that close.

Scale of the business

Senseonics reported revenue of $35.3 million for 2025, up 57% from a year earlier, with a net loss of $69.1 million. Cash and investments totaled $126.3 million as of Sept. 30, 2026, combining $47.8 million in cash and equivalents with $78.5 million in short-term investments.

Recent filing

Senseonics filed a quarterly report on Form 10-Q on Monday, Nov. 9, 2026, one day before the upgrade.

Sources

Written with AI from analyst rating changes, SEC filings and market data, and checked against those sources before publishing. Our editorial standards.

More analyst ratings

SENS page →

Filings, figures and price history are on the Senseonics page.